24 computer-science-programming-languages-"Prof"-"Durham-University" research jobs at MASARYK UNIVERSITY
Sort by
Refine Your Search
-
Department: Department of Regional Economics – Faculty of Economics and Administration Deadline: 31 Jan 2026 Start date: September 1st, 2026 or later Job type: full-time Job field: Science and
-
of neural systems in common programming languages (e.g., MATLAB, Python) Experience in applying computational models to clinical applications — in particular to epilepsy Include these in your application: A
-
Science. Specific qualifications include: Enthusiasm for genomics-oriented research. Proficient programming skills, experience in sequencing data analysis and mining. A robust knowledge of human genetics
-
of Science, Masaryk University announces an open competition for the position POSTDOC POSITION in Computational Condensed Matter Physics Workplace: Department of Condensed Matter Physics, Faculty of Science
-
Department: Lukáš Čajánek Research Group: Laboratory of Cilia and Centrosome Biology – Faculty of Medicine Deadline: 31 Jan 2026 Start date: April 2026 or upon agreement Job type: full-time Job
-
field: Science and research Medical Faculty of Masaryk University, Brno, Czech Republic invites excellent scientists to apply for a two-year POSTDOC POSITION in Cell Biology and Microglia Research
-
Department: Tomáš Bárta Research Group: Stem Cell Biology and Vision Research – Faculty of Medicine Deadline: 31 Jan 2026 Start date: April 2026 or upon agreement Job type: full-time Job field
-
Department: Michal Masařík Research Group: Cancer Research Lab – Faculty of Medicine Deadline: 31 Jan 2026 Start date: April 2026 or upon agreement Job type: full-time Job field: Science and
-
Department: Centre for Modern Art and Theory – Faculty of Arts Deadline: 10 Dec 2025 Start date: 1. 1. 2026 Job type: full-time Job field: Science and research Dean of the Faculty of Arts, Masaryk
-
, Faculty of Medicine We are seeking a motivated researcher or research technician for a program focused on the preclinical development of drugs targeting cell signaling. The successful candidate will